Adaptin Bio, Inc. Financing Cash Flow
Adaptin Bio, Inc. (APTN) reported Financing Cash Flow of $1.26 million for the 6-month period ending 2026-06-30, per its S-1 filed 2026-08-28.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-28
- Adaptin Bio, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $819.34K.
- Adaptin Bio, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $438.43K, a 90.51% decline year-over-year.
- Adaptin Bio, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $582.96K.
- Adaptin Bio, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- Adaptin Bio, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $80.92K.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 10 month | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $819.34K derived: S-1 6 month − POS AM 3 month · filed 2026-08-28 | $1.26M S-1 · filed 2026-08-28 | $1.84M derived: sum of 3 quarters · filed 2026-08-28 | $1.84M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2026-03-31 | $438.43K POS AM · filed 2026-07-21 | $1.02M derived: sum of 2 quarters · filed 2026-08-28 | $1.02M derived: sum of 3 quarters · filed 2026-08-28 | $1.02M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2025-12-31 | $582.96K derived: S-1 12 month − 10-Q 9 month · filed 2026-08-28 | $582.96K derived: sum of 2 quarters · filed 2026-08-28 | $582.96K derived: sum of 3 quarters · filed 2026-08-28 | $5.20M S-1 · filed 2026-08-28 | ||||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − S-1 6 month · filed 2025-11-14 | $0.00 derived: sum of 2 quarters · filed 2026-08-28 | $4.62M 10-Q · filed 2025-11-14 | $4.43M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2025-06-30 | $0.00 derived: S-1 6 month − POS AM 3 month · filed 2026-08-28 | $4.62M S-1 · filed 2026-08-28 | $4.43M derived: sum of 3 quarters · filed 2026-08-28 | $4.99M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2025-03-31 | $4.62M POS AM · filed 2026-07-21 | $4.43M derived: sum of 2 quarters · filed 2026-08-28 | $4.99M derived: sum of 3 quarters · filed 2026-08-28 | $5.21M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2024-12-31 | -$193.88K derived: S-1 12 month − 10-Q 9 month · filed 2026-08-28 | $366.07K derived: sum of 2 quarters · filed 2026-08-28 | $588.61K derived: sum of 3 quarters · filed 2026-08-28 | $678.61K S-1 · filed 2026-08-28 | $193.78K 10-K · filed 2025-04-15 | |||
| 2024-09-30 | $559.95K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $782.49K derived: sum of 2 quarters · filed 2025-11-14 | $872.49K 10-Q · filed 2025-11-14 | $56.55K 10-Q · filed 2024-11-14 | $930.84K derived: sum of 4 quarters · filed 2025-11-14 | |||
| 2024-06-30 | $222.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $312.54K 10-Q · filed 2025-08-14 | $31.35K 10-Q · filed 2024-08-14 | $370.89K derived: sum of 3 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $90.00K 10-Q · filed 2025-05-15 | $148.35K derived: sum of 2 quarters · filed 2025-05-15 | ||||||
| 2023-12-31 | $58.35K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $80.92K 10-K · filed 2025-04-15 | ||||||
| 2023-09-30 | $22.57K 10-Q · filed 2024-11-14 | |||||||
| 2022-12-31 | $804.00 10-K · filed 2024-04-01 | |||||||
| 2022-09-30 | $304.00 10-Q · filed 2023-11-14 |